Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Drug Therapy
1.2.3 Light Therapy
1.3 Market by Application
1.3.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Perspective (2018-2033)
2.2 Sleeplessness and Circadian Rhythm Disorder Treatment Growth Trends by Region
2.2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Region (2018-2023)
2.2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Region (2024-2033)
2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Dynamics
2.3.1 Sleeplessness and Circadian Rhythm Disorder Treatment Industry Trends
2.3.2 Sleeplessness and Circadian Rhythm Disorder Treatment Market Drivers
2.3.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Challenges
2.3.4 Sleeplessness and Circadian Rhythm Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Revenue
3.1.1 Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Revenue (2018-2023)
3.1.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue
3.4 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Concentration Ratio
3.4.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in 2022
3.5 Sleeplessness and Circadian Rhythm Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Sleeplessness and Circadian Rhythm Disorder Treatment Product Solution and Service
3.7 Date of Enter into Sleeplessness and Circadian Rhythm Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sleeplessness and Circadian Rhythm Disorder Treatment Breakdown Data by Type
4.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Type (2018-2023)
4.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Type (2024-2033)
5 Sleeplessness and Circadian Rhythm Disorder Treatment Breakdown Data by Application
5.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Application (2018-2023)
5.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2018-2033)
6.2 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023)
6.4 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2018-2033)
7.2 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023)
7.4 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2018-2033)
8.2 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2018-2033)
9.2 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023)
9.4 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2018-2033)
10.2 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lanaform
11.1.1 Lanaform Company Detail
11.1.2 Lanaform Business Overview
11.1.3 Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.1.4 Lanaform Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.1.5 Lanaform Recent Development
11.2 Compass Health Brands (Carex Health)
11.2.1 Compass Health Brands (Carex Health) Company Detail
11.2.2 Compass Health Brands (Carex Health) Business Overview
11.2.3 Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.2.4 Compass Health Brands (Carex Health) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.2.5 Compass Health Brands (Carex Health) Recent Development
11.3 Compumedics
11.3.1 Compumedics Company Detail
11.3.2 Compumedics Business Overview
11.3.3 Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.3.4 Compumedics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.3.5 Compumedics Recent Development
11.4 Natus Medical
11.4.1 Natus Medical Company Detail
11.4.2 Natus Medical Business Overview
11.4.3 Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.4.4 Natus Medical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.4.5 Natus Medical Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Lucimed (Luminette)
11.6.1 Lucimed (Luminette) Company Detail
11.6.2 Lucimed (Luminette) Business Overview
11.6.3 Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.6.4 Lucimed (Luminette) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.6.5 Lucimed (Luminette) Recent Development
11.7 Garmin
11.7.1 Garmin Company Detail
11.7.2 Garmin Business Overview
11.7.3 Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.7.4 Garmin Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.7.5 Garmin Recent Development
11.8 Koninklijke Philips
11.8.1 Koninklijke Philips Company Detail
11.8.2 Koninklijke Philips Business Overview
11.8.3 Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.8.4 Koninklijke Philips Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.8.5 Koninklijke Philips Recent Development
11.9 Mylan
11.9.1 Mylan Company Detail
11.9.2 Mylan Business Overview
11.9.3 Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.9.4 Mylan Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.9.5 Mylan Recent Development
11.10 Fitbit
11.10.1 Fitbit Company Detail
11.10.2 Fitbit Business Overview
11.10.3 Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.10.4 Fitbit Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.10.5 Fitbit Recent Development
11.11 Takeda Pharmaceutical
11.11.1 Takeda Pharmaceutical Company Detail
11.11.2 Takeda Pharmaceutical Business Overview
11.11.3 Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.11.4 Takeda Pharmaceutical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.11.5 Takeda Pharmaceutical Recent Development
11.12 F.Hoffman La-Roche AG
11.12.1 F.Hoffman La-Roche AG Company Detail
11.12.2 F.Hoffman La-Roche AG Business Overview
11.12.3 F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.12.4 F.Hoffman La-Roche AG Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.12.5 F.Hoffman La-Roche AG Recent Development
11.13 Merck & Co. Inc.
11.13.1 Merck & Co. Inc. Company Detail
11.13.2 Merck & Co. Inc. Business Overview
11.13.3 Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.13.4 Merck & Co. Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.13.5 Merck & Co. Inc. Recent Development
11.14 Pfizer, Inc.
11.14.1 Pfizer, Inc. Company Detail
11.14.2 Pfizer, Inc. Business Overview
11.14.3 Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.14.4 Pfizer, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.14.5 Pfizer, Inc. Recent Development
11.15 Pernix Therapeutics
11.15.1 Pernix Therapeutics Company Detail
11.15.2 Pernix Therapeutics Business Overview
11.15.3 Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.15.4 Pernix Therapeutics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.15.5 Pernix Therapeutics Recent Development
11.16 Sanofi S.A.
11.16.1 Sanofi S.A. Company Detail
11.16.2 Sanofi S.A. Business Overview
11.16.3 Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.16.4 Sanofi S.A. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.16.5 Sanofi S.A. Recent Development
11.17 Sumitomo Dainippon Pharma Co., Ltd
11.17.1 Sumitomo Dainippon Pharma Co., Ltd Company Detail
11.17.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.17.3 Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.17.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.17.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.18 Vanda Pharmaceuticals, Inc.
11.18.1 Vanda Pharmaceuticals, Inc. Company Detail
11.18.2 Vanda Pharmaceuticals, Inc. Business Overview
11.18.3 Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.18.4 Vanda Pharmaceuticals, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
11.18.5 Vanda Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Drug Therapy
Table 3. Key Players of Light Therapy
Table 4. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2018-2023)
Table 8. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2024-2033)
Table 10. Sleeplessness and Circadian Rhythm Disorder Treatment Market Trends
Table 11. Sleeplessness and Circadian Rhythm Disorder Treatment Market Drivers
Table 12. Sleeplessness and Circadian Rhythm Disorder Treatment Market Challenges
Table 13. Sleeplessness and Circadian Rhythm Disorder Treatment Market Restraints
Table 14. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Players (2018-2023)
Table 16. Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment as of 2022)
Table 17. Ranking of Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sleeplessness and Circadian Rhythm Disorder Treatment Product Solution and Service
Table 21. Date of Enter into Sleeplessness and Circadian Rhythm Disorder Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Lanaform Company Detail
Table 47. Lanaform Business Overview
Table 48. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 49. Lanaform Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 50. Lanaform Recent Development
Table 51. Compass Health Brands (Carex Health) Company Detail
Table 52. Compass Health Brands (Carex Health) Business Overview
Table 53. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 54. Compass Health Brands (Carex Health) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 55. Compass Health Brands (Carex Health) Recent Development
Table 56. Compumedics Company Detail
Table 57. Compumedics Business Overview
Table 58. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 59. Compumedics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 60. Compumedics Recent Development
Table 61. Natus Medical Company Detail
Table 62. Natus Medical Business Overview
Table 63. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 64. Natus Medical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 65. Natus Medical Recent Development
Table 66. Teva Pharmaceuticals Company Detail
Table 67. Teva Pharmaceuticals Business Overview
Table 68. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 69. Teva Pharmaceuticals Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 70. Teva Pharmaceuticals Recent Development
Table 71. Lucimed (Luminette) Company Detail
Table 72. Lucimed (Luminette) Business Overview
Table 73. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 74. Lucimed (Luminette) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 75. Lucimed (Luminette) Recent Development
Table 76. Garmin Company Detail
Table 77. Garmin Business Overview
Table 78. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 79. Garmin Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 80. Garmin Recent Development
Table 81. Koninklijke Philips Company Detail
Table 82. Koninklijke Philips Business Overview
Table 83. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 84. Koninklijke Philips Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 85. Koninklijke Philips Recent Development
Table 86. Mylan Company Detail
Table 87. Mylan Business Overview
Table 88. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 89. Mylan Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 90. Mylan Recent Development
Table 91. Fitbit Company Detail
Table 92. Fitbit Business Overview
Table 93. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 94. Fitbit Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 95. Fitbit Recent Development
Table 96. Takeda Pharmaceutical Company Detail
Table 97. Takeda Pharmaceutical Business Overview
Table 98. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 99. Takeda Pharmaceutical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 100. Takeda Pharmaceutical Recent Development
Table 101. F.Hoffman La-Roche AG Company Detail
Table 102. F.Hoffman La-Roche AG Business Overview
Table 103. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 104. F.Hoffman La-Roche AG Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 105. F.Hoffman La-Roche AG Recent Development
Table 106. Merck & Co. Inc. Company Detail
Table 107. Merck & Co. Inc. Business Overview
Table 108. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 109. Merck & Co. Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 110. Merck & Co. Inc. Recent Development
Table 111. Pfizer, Inc. Company Detail
Table 112. Pfizer, Inc. Business Overview
Table 113. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 114. Pfizer, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 115. Pfizer, Inc. Recent Development
Table 116. Pernix Therapeutics Company Detail
Table 117. Pernix Therapeutics Business Overview
Table 118. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 119. Pernix Therapeutics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 120. Pernix Therapeutics Recent Development
Table 121. Sanofi S.A. Company Detail
Table 122. Sanofi S.A. Business Overview
Table 123. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 124. Sanofi S.A. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 125. Sanofi S.A. Recent Development
Table 126. Sumitomo Dainippon Pharma Co., Ltd Company Detail
Table 127. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 128. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 129. Sumitomo Dainippon Pharma Co., Ltd Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 130. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 131. Vanda Pharmaceuticals, Inc. Company Detail
Table 132. Vanda Pharmaceuticals, Inc. Business Overview
Table 133. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 134. Vanda Pharmaceuticals, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023) & (US$ Million)
Table 135. Vanda Pharmaceuticals, Inc. Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type: 2022 VS 2033
Figure 3. Drug Therapy Features
Figure 4. Light Therapy Features
Figure 5. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Specialist Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Sleeplessness and Circadian Rhythm Disorder Treatment Report Years Considered
Figure 11. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Players in 2022
Figure 15. Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in 2022
Figure 17. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2018-2033)
Figure 19. United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2018-2033)
Figure 23. Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2018-2033)
Figure 31. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2018-2033)
Figure 39. Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2018-2033)
Figure 43. Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Lanaform Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 46. Compass Health Brands (Carex Health) Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 47. Compumedics Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 48. Natus Medical Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 50. Lucimed (Luminette) Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 51. Garmin Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 52. Koninklijke Philips Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 53. Mylan Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 54. Fitbit Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 55. Takeda Pharmaceutical Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 56. F.Hoffman La-Roche AG Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 57. Merck & Co. Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 58. Pfizer, Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 59. Pernix Therapeutics Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 60. Sanofi S.A. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 61. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 62. Vanda Pharmaceuticals, Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed